SAN JOSE, Calif.--(BUSINESS WIRE)--Labcyte Inc. today announced that the American Institute for Medical and Biological Engineering (AIMBE) has inducted Sammy S. Datwani, Ph.D., Sr. Director, Principal Engineer, R&D at Labcyte to its College of Fellows. Dr. Datwani was nominated, reviewed, and elected by peers and members of the College of Fellows for contributions to leveraging microscale phenomena to enable label-free and high-throughput experimentation, screening and precision medicine.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to "engineering and medicine research, practice, or education” and to "the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education."
Dr. Datwani joined Labcyte in 2007 and is responsible for leading internal research programs and managing the advanced developments for the creation of new products and capabilities for the company in the arena of acoustic droplet ejection. Dr. Datwani has over twenty years of experience directing, managing, inventing and applying cutting edge research and developments in both industry and academia. Prior to Labcyte, he was a Senior Scientist and the Advanced Technologies Group Manager at Eksigent Technologies, LLC. From 2000 – 2003, he held the position of R&D Engineer in the Advanced Technology Group at Caliper Life Sciences and spearheaded the development of several LabChip® devices.
Dr. Datwani graduated with honors from The Johns Hopkins University with a B.S. in Chemical and Biomolecular Engineering. He holds a M.S. degree from The Columbia University in Chemical Engineering with a concentration in Polymer Science. He earned his Ph.D. in Chemical and Biomolecular Engineering from The Johns Hopkins University. Since 2011, Dr. Datwani has held an appointment as an Adjunct Professor in the Department of Biomedical, Chemical & Materials Engineering at San Jose State University.
Labcyte Chief Executive Officer Mark Fischer-Colbrie commented: “Sammy’s knowledge, skill-set and leadership put him at the top of his field, and we are proud to have him as part of our team. Over the past decade he has made many notable contributions to advancing our acoustic dispensing technology and helped us attain leadership in our field. I warmly congratulate him on behalf of all of us at Labcyte.”
A formal induction ceremony was held during the AIMBE Annual Meeting at the National Academy of Sciences in Washington, DC on April 9, 2018. Dr. Datwani was inducted along with 156 colleagues who make up the AIMBE College of Fellows Class of 2018.
AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. AIMBE’s mission is to recognize excellence, advance the public understanding, and accelerate medical and biological innovation. No other organization can bring together academic, industry, government, and scientific societies to form a highly influential community advancing medical and biological engineering. AIMBE’s mission drives advocacy initiatives into action on Capitol Hill and beyond. For more information about the AIMBE, please visit www.aimbe.org.
About Labcyte Inc.
Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® Liquid Handlers use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 62 U.S. patents and others internationally. For more information, visit www.labcyte.com.